Sandra Horning - 14 Jun 2024 Form 4 Insider Report for Olema Pharmaceuticals, Inc. (OLMA)

Role: Director
Signature: /s/ Shane Kovacs, Attorney-in-Fact
Issuer symbol: OLMA
Transactions as of: 14 Jun 2024
Net transactions value: $0
Form type: 4
Filing time: 18 Jun 2024, 17:00:25 UTC
Previous filing: 09 May 2024
Next filing: 24 Jun 2024
SEC: View on sec.gov

Quoteable Key Fact

"Sandra Horning filed Form 4 for Olema Pharmaceuticals, Inc. (OLMA) on 18 Jun 2024."

Quick Takeaways

This page summarizes Sandra Horning's Form 4 filing for Olema Pharmaceuticals, Inc. (OLMA).
1 reported transaction and 1 derivative row are listed below.
Filing timestamp: 18 Jun 2024, 17:00.

What Changed

Previous filing in this sequence was filed on 09 May 2024.
Current net transaction value: $0.

Why This Matters

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Source Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

See Original Filing

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	OLMA	Stock Option (right to buy)	Award	$0	+23,000		$0.000000	23,000	14 Jun 2024	Common Stock	23,000	$12.36	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The shares subject to the option vest in a series of 12 successive equal monthly installments measured from June 14, 2024, subject to the Reporting Person's continuous service through each applicable vesting date. Such shares vest in full on the date of the Issuer's next annual meeting of stockholders if such stock option is not otherwise fully vested by such date, subject to the Reporting Person's continuous service through such vesting date.

Content

The shares subject to the option vest in a series of 12 successive equal monthly installments measured from June 14, 2024, subject to the Reporting Person's continuous service through each applicable vesting date. Such shares vest in full on the date of the Issuer's next annual meeting of stockholders if such stock option is not otherwise fully vested by such date, subject to the Reporting Person's continuous service through such vesting date.